BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Boo YJ, Park SS, Kim JH, Mok YJ, Kim SJ, Kim CS. Gastric neuroendocrine carcinoma: clinicopathologic review and immunohistochemical study of E-cadherin and Ki-67 as prognostic markers. J Surg Oncol. 2007;95:110-117. [PMID: 17066436 DOI: 10.1002/jso.20616] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Mizoshita T, Kataoka H, Kubota E, Shimura T, Mori Y, Wada T, Ogasawara N, Sasaki M, Kamiya T, Sakamoto M, Akamo Y, Joh T. AN ENDOCRINE CELL CARCINOMA WITH GASTRIC-AND-INTESTINAL MIXED PHENOTYPE ADENOCARCINOMA COMPONENT IN THE STOMACH. Digestive Endoscopy 2009;21:258-61. [DOI: 10.1111/j.1443-1661.2009.00903.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
2 Xie JW, Lu J, Lin JX, Zheng CH, Li P, Wang JB, Chen QY, Cao LL, Lin M, Tu RH, Huang CM. Different long-term oncologic outcomes after radical surgical resection for neuroendocrine carcinoma and adenocarcinoma of the stomach. Oncotarget 2017;8:57495-504. [PMID: 28915689 DOI: 10.18632/oncotarget.15488] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
3 Kubota T, Ohyama S, Hiki N, Nunobe S, Yamamoto N, Yamaguchi T. Endocrine carcinoma of the stomach: clinicopathological analysis of 27 surgically treated cases in a single institute. Gastric Cancer. 2012;15:323-330. [PMID: 22252152 DOI: 10.1007/s10120-011-0122-5] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
4 Ren H, Shi SS, Wang NC, Wang X, Chen YT, Zhao DB. The Significant Influence of the Neuroendocrine Component on the Survival of Patients with Gastric Carcinoma Characterized by Coexisting Exocrine and Neuroendocrine Components. J Oncol 2019;2019:3671268. [PMID: 30992704 DOI: 10.1155/2019/3671268] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Zhang Y, Li C, Chen M. Prognostic value of immunohistochemical factors in esophageal small cell carcinoma (ESCC): analysis of clinicopathologic features of 73 patients. J Thorac Dis 2018;10:4023-31. [PMID: 30174845 DOI: 10.21037/jtd.2018.06.26] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
6 Makis W, Ciarallo A, Hickeson M, Derbekyan V, Novales-diaz J, Lisbona R. Gastric Neuroendocrine Carcinoma Staged and Followed With 18F-FDG PET/CT—A Report of 3 Cases. Clinical Nuclear Medicine 2013;38:447-50. [DOI: 10.1097/rlu.0b013e31828da1f5] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
7 Kataoka H, Mori Y, Shimura T, Nishie H, Natsume M, Mochizuki H, Hirata Y, Sobue S, Mizushima T, Sano H, Mizuno Y, Nakamura M, Hirano A, Tsuchida K, Adachi K, Seno K, Kitagawa M, Kawai T, Joh T. A phase II prospective study of the trastuzumab combined with 5-weekly S-1 and CDDP therapy for HER2-positive advanced gastric cancer. Cancer Chemother Pharmacol 2016;77:957-62. [DOI: 10.1007/s00280-016-3013-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
8 Xie JW, Sun YQ, Feng CY, Zheng CH, Li P, Wang JB, Lin JX, Lu J, Chen QY, Cao LL. Evaluation of clinicopathological factors related to the prognosis of gastric neuroendocrine carcinoma. Eur J Surg Oncol. 2016;42:1464-1470. [PMID: 27570115 DOI: 10.1016/j.ejso.2016.08.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
9 Araki T, Takashima A, Hamaguchi T, Honma Y, Iwasa S, Okita N, Kato K, Yamada Y, Hashimoto H, Taniguchi H, Kushima R, Nakao K, Boku N, Shimada Y. Amrubicin in patients with platinum-refractory metastatic neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma of the gastrointestinal tract. Anti-Cancer Drugs 2016;27:794-9. [DOI: 10.1097/cad.0000000000000393] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
10 Hsu CY, Yang CF, Liao LR, Ho HL, Ho DM. Tonsil surface epithelium is ideal for monitoring Ki-67 immunohistochemical staining. Histopathology 2013;63:810-6. [PMID: 24024498 DOI: 10.1111/his.12228] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
11 Waldum HL, Ringnes E, Nordbø H, Sørdal Ø, Nordrum IS, Hauso Ø. The normal neuroendocrine cells of the upper gastrointestinal tract lack E-cadherin. Scand J Gastroenterol 2014;49:974-8. [PMID: 24742175 DOI: 10.3109/00365521.2014.909275] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
12 Uchiyama C, Tamura S, Nakatsuka S, Takeno A, Miki H, Kanemura T, Nakahira S, Suzuki R, Nakata K, Takeda Y, Kato T. Immunohistochemical consistency between primary tumors and lymph node metastases of gastric neuroendocrine carcinoma. World J Surg Oncol 2012;10:115. [PMID: 22726317 DOI: 10.1186/1477-7819-10-115] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
13 Waldum H. Tumor Classification Should Be Based on Biology and Not Consensus: Re-Defining Tumors Based on Biology May Accelerate Progress, An Experience of Gastric Cancer. Cancers (Basel) 2021;13:3159. [PMID: 34202596 DOI: 10.3390/cancers13133159] [Reference Citation Analysis]
14 Ainechi S, Mann SA, Lin J, Patil D, Sheehan CE, Yang Z, Zuo C, Lee H. Paired Box 5 (PAX5) Expression in Poorly Differentiated Neuroendocrine Carcinoma of the Gastrointestinal and Pancreatobiliary Tract: Diagnostic and Potentially Therapeutic Implications. Appl Immunohistochem Mol Morphol 2018;26:545-51. [PMID: 27941564 DOI: 10.1097/PAI.0000000000000473] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
15 Walenkamp A, Crespo G, Fierro Maya F, Fossmark R, Igaz P, Rinke A, Tamagno G, Vitale G, Öberg K, Meyer T. Hallmarks of gastrointestinal neuroendocrine tumours: implications for treatment. Endocr Relat Cancer 2014;21:R445-60. [PMID: 25296914 DOI: 10.1530/ERC-14-0106] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
16 Frilling A, Li J, Malamutmann E, Schmid KW, Bockisch A, Broelsch CE. Treatment of liver metastases from neuroendocrine tumours in relation to the extent of hepatic disease. Br J Surg 2009;96:175-84. [PMID: 19160361 DOI: 10.1002/bjs.6468] [Cited by in Crossref: 141] [Cited by in F6Publishing: 110] [Article Influence: 10.8] [Reference Citation Analysis]
17 Girardi DM, Silva ACB, Rêgo JFM, Coudry RA, Riechelmann RP. Unraveling molecular pathways of poorly differentiated neuroendocrine carcinomas of the gastroenteropancreatic system: A systematic review. Cancer Treat Rev 2017;56:28-35. [PMID: 28456055 DOI: 10.1016/j.ctrv.2017.04.002] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 6.0] [Reference Citation Analysis]
18 Ilett EE, Langer SW, Olsen IH, Federspiel B, Kjær A, Knigge U. Neuroendocrine Carcinomas of the Gastroenteropancreatic System: A Comprehensive Review. Diagnostics (Basel) 2015;5:119-76. [PMID: 26854147 DOI: 10.3390/diagnostics5020119] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 7.1] [Reference Citation Analysis]
19 Stojsic Z, Brasanac D, Bilanovic D, Mitrovic O, Stevanovic R, Boricic I. Large-cell neuroendocrine carcinoma of the ampulla of Vater. Med Oncol 2010;27:1144-8. [PMID: 19898974 DOI: 10.1007/s12032-009-9350-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
20 Jiang M, Tan Y, Li X, Fu J, Hu H, Ye X, Cao Y, Xu J, Yuan Y. Clinicopathological Features and Prognostic Factors of Colorectal Neuroendocrine Neoplasms. Gastroenterol Res Pract 2017;2017:4206172. [PMID: 28194176 DOI: 10.1155/2017/4206172] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
21 Deng Y, Chen X, Ye Y, Shi X, Zhu K, Huang L, Zhang S, Ying M, Lin X. Histological characterisation and prognostic evaluation of 62 gastric neuroendocrine carcinomas. Contemp Oncol (Pozn) 2016;20:311-9. [PMID: 27688729 DOI: 10.5114/wo.2016.61852] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
22 Shida T, Furuya M, Kishimoto T, Nikaido T, Tanizawa T, Koda K, Oda K, Takano S, Kimura F, Shimizu H, Yoshidome H, Ohtsuka M, Nakatani Y, Miyazaki M. The expression of NeuroD and mASH1 in the gastroenteropancreatic neuroendocrine tumors. Mod Pathol 2008;21:1363-70. [DOI: 10.1038/modpathol.2008.121] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
23 Namikawa T, Oki T, Kitagawa H, Okabayashi T, Kobayashi M, Hanazaki K. Neuroendocrine carcinoma of the stomach: clinicopathological and immunohistochemical evaluation. Med Mol Morphol. 2013;46:34-40. [PMID: 23306663 DOI: 10.1007/s00795-012-0006-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
24 Terada T, Maruo H. Simultaneous large cell neuroendocrine carcinoma and adenocarcinoma of the stomach. World J Gastroenterol 2011; 17(43): 4831-4834 [PMID: 22147986 DOI: 10.3748/wjg.v17.i43.4831] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
25 Monteiro de Melo Santos D, López-Tomassetti Fernández E, Sánchez Ramos M, Hernández Hernández JR. Improved survival with palliative surgery and chemotherapy for Mixed adenoneuroendocrine carcinoma of the gastroesophageal junction with liver metastases. Cir Esp (Engl Ed) 2018;96:58-61. [PMID: 28687256 DOI: 10.1016/j.ciresp.2017.03.014] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Koenig A, Krug S, Mueller D, Barth PJ, Koenig U, Scharf M, Ellenrieder V, Michl P, Moll R, Homayunfar K, Kann PH, Stroebel P, Gress TM, Rinke A. Clinicopathological hallmarks and biomarkers of colorectal neuroendocrine neoplasms. PLoS One 2017;12:e0188876. [PMID: 29232390 DOI: 10.1371/journal.pone.0188876] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
27 Li X, Shao L, Lu X, Yang Z, Ai S, Sun F, Wang M, Guan W, Liu S. Risk factors for lymph node metastasis in gastric neuroendocrine tumor: a retrospective study. BMC Surg 2021;21:174. [PMID: 33789664 DOI: 10.1186/s12893-021-01174-7] [Reference Citation Analysis]